产品名称
丙吡胺, European Pharmacopoeia (EP) Reference Standard
InChI
1S/C21H29N3O/c1-16(2)24(17(3)4)15-13-21(20(22)25,18-10-6-5-7-11-18)19-12-8-9-14-23-19/h5-12,14,16-17H,13,15H2,1-4H3,(H2,22,25)
SMILES string
CC(C)N(CCC(C(N)=O)(c1ccccc1)c2ccccn2)C(C)C
InChI key
UVTNFZQICZKOEM-UHFFFAOYSA-N
grade
pharmaceutical primary standard
API family
disopyramide
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
Gene Information
正在寻找类似产品? 访问 产品对比指南
Biochem/physiol Actions
IA 类抗心律失常药；钠通道阻断剂
Application
Disopyramide EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Other Notes
Sales restrictions may apply.
Packaging
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Repr. 2
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
[Disopyramide, mexiletine, aprindine].
M Suzuki
Nihon rinsho. Japanese journal of clinical medicine, 53 Su Pt 1, 989-993 (1995-02-01)
[Hypoglycemia caused by disopyramide: physiopathology].
S Hadjadj et al.
Annales de medecine interne, 146(3), 209-210 (1995-01-01)
[Hypoglycemia induced or facilitated by disopyramide].
C Seriès
La Revue de medecine interne, 9(5), 528-529 (1988-11-01)
B Brembilla-Perrot et al.
Archives des maladies du coeur et des vaisseaux, 84(6), 837-842 (1991-06-01)
The aim of this study was to assess the effect of delayed release Disopyramide 500 mg daily on sinus node function in 12 subjects with sinus node dysfunction and supraventricular and/or ventricular excitability. An ECG, Holter monitoring and electrophysiological studies
R N Brogden et al.
Drugs, 34(2), 151-187 (1987-08-01)
Disopyramide is a widely used class IA antiarrhythmic drug with a pharmacological profile of action similar to that of quinidine and procainamide. Over the past 10 years disopyramide has demonstrated its efficacy in ventricular and atrial arrhythmias. In therapeutic trials
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持